Please login to the form below

Not currently logged in
Email:
Password:

Kalina Scott joins Switzerland's Polyphor

Moves from Bank am Bellevue to take up CFO role at the pharma company

Switzerland-based pharmaceutical company Polyphor has appointed Kalina Scott as its chief financial officer.

She has over 20 years’ experience in mergers, acquisitions, capital markets and private placements particularly in the healthcare field, and has joined the privately-owned company from Bank Am Bellevue where she served as managing director.

She said: “I am honoured and very excited about the opportunity to support Polyphor in its goal to become the leader in the development of powerful therapies that help patients to improve their lives and bring value to shareholders.”

During her career Scott has worked with a number of corporate companies and medical groups including Molecular Partners, Cassiopea, Galenica Santé, Mathys Medical and Sulzer Medica.

Giacomo Di Nepi, CEO of Polyphor, said: “I am very pleased that Kalina has decided to join Polyphor.

“Her extensive experience in the finance area, combined with her transaction-based expertise in healthcare and her broad network will help grow Polyphor and support our corporate strategy and transformation.”

Scott succeeds Alain Schaffter who will leave Polyphor to take on a what the company said would be a new challenge.

7th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics